Barrett's oesophagus: Evidence from the current meta-analyses

Area of Science:

• Gastroenterology and Oncology
• Epidemiology of Esophageal Diseases

Background:

• Current guidelines for Barrett's oesophagus management focus on surveillance for dysplasia and early cancer.
• The evidence base for cancer risk stratification in existing guidelines is limited.
• Recent meta-analyses provide updated data on risk factors and management strategies.

Purpose of the Study:

• To critically evaluate the evidence supporting current Barrett's oesophagus surveillance guidelines.
• To identify key risk factors for cancer development in Barrett's oesophagus.
• To assess the efficacy of different management strategies based on recent meta-analyses.

Main Methods:

• Systematic review of meta-analyses published up to April 2013.
• Analysis of 9 meta-analyses comparing Barrett's oesophagus patients to controls.
• Analysis of 8 meta-analyses comparing different patient groups within Barrett's oesophagus regarding cancer risk.

Main Results:

• Barrett's oesophagus is associated with male gender, smoking, obesity, GERD, H. pylori negativity, and hiatus hernia.
• Antireflux surgery showed no benefit over medical therapy.
• Endoscopic ablative therapy reduced cancer risk.
• Cancer risk is similar across geographic origins.
• Adenocarcinoma incidence is twice as high in males.
• Long segment disease and low-grade dysplasia showed trends towards higher risk.
• H. pylori infection, aspirin, and statins demonstrated protective effects.

Conclusions:

• Current surveillance guidelines based on intestinal metaplasia, segment length, and low-grade dysplasia have a weak evidence base.
• Gender and H. pylori status are important considerations for risk stratification.
• Ablation of metaplastic segments and chemoprotection with aspirin/statins warrant further consideration.